Final product composition after ex-vivo T-cell reduction:...

Cytotherapy 2013 / 4 Vol. 15; Iss. 4

Final product composition after ex-vivo T-cell reduction: Miltenyi CliniMACS versus Baxter Isolex 300I in a large cohort of allogeneic trans-plant patients

Tonon, J., Koehne, G., Collins, N.H., Malloy, M., Chen, X., Bleau, S., Pessin, M., Smith, K., Maslak, P., Devlin, S., Giralt, S.A., O'Reilly, R.J., Jakubowski, A.A., Meagher, R.C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
15
Language:
english
Journal:
Cytotherapy
DOI:
10.1016/j.jcyt.2013.01.083
Date:
April, 2013
File:
PDF, 65 KB
english, 2013
Conversion to is in progress
Conversion to is failed